Metric Snapshot
- Latest value
- -208%
- Coverage range
- 30 Sep 2014 - 31 Dec 2025
- Fact rows
- 58
Shareable Research Card
ARMP - Armata Pharmaceuticals, Inc. Return On Assets
This metric view shows ARMP - Armata Pharmaceuticals, Inc. return on assets history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2025
- Latest reported value
- -208%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
Armata Pharmaceuticals, Inc.: Return On Assets
Latest period: Q4 2025. Period end: 31 Dec 2025. Units: %. Frequency: quarterly and annual.
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
What This Metric Tells You
- Shows the reported level of return on assets over 30 Sep 2014 - 31 Dec 2025.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 58 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Return On Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | GROOVY COMPANY, INC. ([]) | 8411% | Quarter - 30 Sep 2025 | Open GROOVY COMPANY, INC. Return On Assets |
| 2 | Cannonau Corp. (["cnnc"]) | 5050% | Year - 31 Dec 2023 | Open Cannonau Corp. Return On Assets |
| 3 | NovelStem International Corp. (["nstm"]) | 4859% | Year - 31 Dec 2025 | Open NovelStem International Corp. Return On Assets |
| 4 | Fyntechnical Innovations Inc (["fynn"]) | 3567% | Quarter - 30 Sep 2025 | Open Fyntechnical Innovations Inc Return On Assets |
| 5 | Galera Therapeutics, Inc. (["grtx"]) | 2301% | Year - 31 Dec 2025 | Open Galera Therapeutics, Inc. Return On Assets |
| 6 | CuraScientific Corp. ([]) | 2235% | Quarter - 30 Sep 2023 | Open CuraScientific Corp. Return On Assets |
Metric Details
- Metric
- Return On Assets (ROA)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 30 Sep 2014 - 31 Dec 2025
- Facts on this page
- 58
- Description
- Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)
Armata Pharmaceuticals, Inc. Quarterly Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -208% | -190% | -1036% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -55% | -16% | -40% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -29% | +32% | +52% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -0.45% | +73% | +99% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -18% | +47% | +72% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -39% | +18% | +32% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -61% | -24% | -64% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -74% | -31% | -72% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -66% | -28% | -77% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -57% | -22% | -62% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -37% | -0.4% | -1.1% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -43% | -3.4% | -8.7% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -37% | +6.2% | +14% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -35% | +17% | +32% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -37% | +15% | +29% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -39% | +8.8% | +18% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -43% | +6.3% | +13% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -52% | -2.9% | -5.8% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -52% | +5.8% | +10% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -48% | +14% | +23% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -50% | +29% | +37% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -49% | +53% | +52% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -58% | +48% | +45% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -62% | +87% | +58% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -78% | +52% | +40% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | -102% | -6.5% | -6.8% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | -105% | -31% | -42% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | -149% | -55% | -59% | 01 Jan 2019 | 31 Mar 2019 |
| Q4 2018 | -130% | -36% | -38% | 01 Oct 2018 | 31 Dec 2018 |
| Q3 2018 | -95% | +35% | +27% | 01 Jul 2018 | 30 Sep 2018 |
| Q2 2018 | -74% | +43% | +37% | 01 Apr 2018 | 30 Jun 2018 |
| Q1 2018 | -94% | -7.1% | -8.2% | 01 Jan 2018 | 31 Mar 2018 |
| Q4 2017 | -95% | -20% | -28% | 01 Oct 2017 | 31 Dec 2017 |
| Q3 2017 | -130% | -90% | -224% | 01 Jul 2017 | 30 Sep 2017 |
| Q2 2017 | -117% | -105% | -861% | 01 Apr 2017 | 30 Jun 2017 |
| Q1 2017 | -86% | -120% | -359% | 01 Jan 2017 | 31 Mar 2017 |
| Q4 2016 | -74% | -73% | -4944% | 01 Oct 2016 | 31 Dec 2016 |
| Q3 2016 | -40% | -43% | -1417% | 01 Jul 2016 | 30 Sep 2016 |
| Q2 2016 | -12% | -62% | -125% | 01 Apr 2016 | 30 Jun 2016 |
| Q1 2016 | 33% | -26% | -44% | 01 Jan 2016 | 31 Mar 2016 |
| Q4 2015 | -1.5% | -71% | -102% | 01 Oct 2015 | 31 Dec 2015 |
| Q3 2015 | 3% | -64% | -95% | 01 Jul 2015 | 30 Sep 2015 |
| Q2 2015 | 50% | 01 Apr 2015 | 30 Jun 2015 | ||
| Q1 2015 | 60% | 01 Jan 2015 | 31 Mar 2015 | ||
| Q4 2014 | 70% | 01 Oct 2014 | 31 Dec 2014 | ||
| Q3 2014 | 67% | 01 Jul 2014 | 30 Sep 2014 |
Armata Pharmaceuticals, Inc. Annual Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -208% | -190% | -1036% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -18% | +47% | +72% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -66% | -28% | -77% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -37% | +6.2% | +14% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -43% | +6.3% | +13% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -50% | +29% | +37% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -78% | +52% | +40% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -130% | -36% | -38% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | -95% | -20% | -28% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | -74% | -73% | -4944% | 01 Jan 2016 | 31 Dec 2016 |
| 2015 | -1.5% | -71% | -102% | 01 Jan 2015 | 31 Dec 2015 |
| 2014 | 70% | 01 Jan 2014 | 31 Dec 2014 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.